{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T15:08:12Z","timestamp":1767971292621,"version":"3.49.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T00:00:00Z","timestamp":1745280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T00:00:00Z","timestamp":1745280000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100005230","name":"Natural Science Foundation of Chongqing Municipality","doi-asserted-by":"publisher","award":["CSTB2024NSCQ-MSX0190"],"award-info":[{"award-number":["CSTB2024NSCQ-MSX0190"]}],"id":[{"id":"10.13039\/501100005230","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Project of Young and Middle-aged High-level Medical Professional of Chongqing","award":["YXGD202455"],"award-info":[{"award-number":["YXGD202455"]}]},{"name":"Project of science and technology planning of Jiulongpo District","award":["2023-02-036-Z"],"award-info":[{"award-number":["2023-02-036-Z"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastrointest Canc"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s12029-025-01232-w","type":"journal-article","created":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T12:37:38Z","timestamp":1745325458000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Advances and Challenges in the Application of Novel Oral Anticoagulants for Venous Thromboembolism Prevention Following Colorectal Cancer Surgery"],"prefix":"10.1007","volume":"56","author":[{"given":"Yang","family":"Kun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6238-8117","authenticated-orcid":false,"given":"Zhao","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,22]]},"reference":[{"key":"1232_CR1","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1378\/chest.126.3_suppl.338S","volume":"126","author":"WH Geerts","year":"2004","unstructured":"Geerts WH, Pineo GF, Heit JA, Bergqvist D, Lassen MR, Colwell CW, Ray JG. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126:338\u2013400.","journal-title":"Chest"},{"key":"1232_CR2","first-page":"CD004318","volume":"8","author":"S Felder","year":"2019","unstructured":"Felder S, Rasmussen MS, King R, Sklow B, Kwaan M, Madoff R, Jensen C. Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery. Cochrane Database Syst Rev. 2019;8:CD004318.","journal-title":"Cochrane Database Syst Rev"},{"key":"1232_CR3","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.asjsur.2018.12.013","volume":"42","author":"S Emoto","year":"2019","unstructured":"Emoto S, Nozawa H, Kawai K, Hata K, Tanaka T, Shuno Y, Nishikawa T, Sasaki K, Kaneko M, Hiyoshi M, Murono K, Ishihara S. Venous thromboembolism in colorectal surgery: incidence, risk factors, and prophylaxis. Asian J Surg. 2019;42:863\u201373.","journal-title":"Asian J Surg"},{"key":"1232_CR4","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1097\/00000658-200103000-00020","volume":"233","author":"RS McLeod","year":"2001","unstructured":"McLeod RS, Geerts WH, Sniderman KW, Greenwood C, Gregoire RC, Taylor BM, Silverman RE, Atkinson KG, Burnstein M, Marshall JC, Burul CJ, Anderson DR, Ross T, Wilson SR, Barton P. Subcutaneous heparin versus low-molecular-weight heparin as thromboprophylaxis in patients undergoing colorectal surgery: results of the Canadian colorectal DVT prophylaxis trial: a randomized, double-blind trial. Ann Surg. 2001;233:438\u201344.","journal-title":"Ann Surg"},{"key":"1232_CR5","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1001\/jamasurg.2015.1057","volume":"150","author":"DW Nelson","year":"2015","unstructured":"Nelson DW, Simianu VV, Bastawrous AL, Billingham RP, Fichera A, Florence MG, Johnson EK, Johnson MG, Thirlby RC, Flum DR, Steele SR. Thromboembolic complications and prophylaxis patterns in colorectal surgery. JAMA Surg. 2015;150:712\u201320.","journal-title":"JAMA Surg"},{"key":"1232_CR6","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1097\/DCR.0000000000001557","volume":"63","author":"SV Patel","year":"2020","unstructured":"Patel SV, Zhang L, Wei XS, Merchant SJ, Nanji S, James PD, Booth CM. A population-based cohort study of venous thromboembolism rates following surgery and during adjuvant chemotherapy in patients with colon cancer. Dis Colon Rectum. 2020;63:336\u201345.","journal-title":"Dis Colon Rectum"},{"key":"1232_CR7","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1001\/jamasurg.2013.3172","volume":"149","author":"VQ Trinh","year":"2014","unstructured":"Trinh VQ, Karakiewicz PI, Sammon J, Sun M, Sukumar S, Gervais MK, Shariat SF, Tian Z, Kim SP, Kowalczyk KJ, Hu JC, Menon M, Trinh QD. Venous thromboembolism after major cancer surgery: temporal trends and patterns of care. JAMA Surg. 2014;149:43\u20139.","journal-title":"JAMA Surg"},{"key":"1232_CR8","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1097\/DCR.0000000000002975","volume":"66","author":"SV Patel","year":"2023","unstructured":"Patel SV, Liberman SA, Burgess PL, Goldberg JE, Poylin VY, Messick CA, Davis BR, Feingold DL, Lightner AL, Paquette IM. The American Society of Colon and Rectal Surgeons clinical practice guidelines for the reduction of venous thromboembolic disease in colorectal surgery. Dis Colon Rectum. 2023;66:1162\u201373.","journal-title":"Dis Colon Rectum"},{"key":"1232_CR9","doi-asserted-by":"publisher","first-page":"e207410","DOI":"10.1001\/jamanetworkopen.2020.7410","volume":"3","author":"SR Guntupalli","year":"2020","unstructured":"Guntupalli SR, Brennecke A, Behbakht K, Tayebnejad A, Breed CA, Babayan LM, Cheng G, Ramzan AA, Wheeler LJ, Corr BR, Lefkowits C, Sheeder J, Matsuo K, Flink D. Safety and efficacy of apixaban vs enoxaparin for preventing postoperative venous thromboembolism in women undergoing surgery for gynecologic malignant neoplasm: a randomized clinical trial. JAMA Netw Open. 2020;3:e207410.","journal-title":"JAMA Netw Open"},{"key":"1232_CR10","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1160\/TH11-07-0464","volume":"107","author":"D Bergqvist","year":"2012","unstructured":"Bergqvist D, Arcelus JI, Felicissimo P. Post-discharge compliance to venous thromboembolism prophylaxis in high-risk orthopaedic surgery: results from the ETHOS registry. Thromb Haemost. 2012;107:280\u20137.","journal-title":"Thromb Haemost"},{"key":"1232_CR11","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1097\/JU.0000000000002788","volume":"208","author":"ME Westerman","year":"2022","unstructured":"Westerman ME, Bree KK, Msaouel P, Kukreja JB, Mantaring C, Rukundo I, Gonzalez MG, Gregg JR, Casteel KN, Matin SF. Apixaban vs enoxaparin for post-surgical extended-duration venous thromboembolic event prophylaxis: a prospective quality improvement study. J Urol. 2022;208:886\u201395.","journal-title":"J Urol"},{"key":"1232_CR12","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1001\/jama.2023.7843","volume":"329","author":"D Schrag","year":"2023","unstructured":"Schrag D, Uno H, Rosovsky R, Rutherford C, Sanfilippo K, Villano JL, Drescher M, Jayaram N, Holmes C, Feldman L, Zattra O, Farrar-Muir H, Cronin C, Basch E, Weiss A, Connors JM, Investigators C. Direct oral anticoagulants vs low-molecular-weight heparin and recurrent VTE in patients with cancer: a randomized clinical trial. JAMA. 2023;329:1924\u201333.","journal-title":"JAMA"},{"key":"1232_CR13","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1111\/jth.14219","volume":"16","author":"AA Khorana","year":"2018","unstructured":"Khorana AA, Noble S, Lee AYY, Soff G, Meyer G, O\u2019Connell C, Carrier M. Role of direct oral anticoagulants in the treatment of cancer-associated venous thromboembolism: guidance from the SSC of the ISTH. J Thromb Haemost. 2018;16:1891\u20134.","journal-title":"J Thromb Haemost"},{"key":"1232_CR14","doi-asserted-by":"publisher","first-page":"103074","DOI":"10.1016\/j.critrevonc.2020.103074","volume":"154","author":"M Camilli","year":"2020","unstructured":"Camilli M, Lombardi M, Vescovo GM, Del Buono MG, Galli M, Aspromonte N, Zoccai GB, Niccoli G, Montone RA, Crea F, Minotti G. Efficacy and safety of novel oral anticoagulants versus low molecular weight heparin in cancer patients with venous thromboembolism: a systematic review and meta-analysis. Crit Rev Oncol Hematol. 2020;154:103074.","journal-title":"Crit Rev Oncol Hematol"},{"key":"1232_CR15","doi-asserted-by":"publisher","first-page":"793","DOI":"10.2147\/VHRM.S271411","volume":"18","author":"LM Attard","year":"2022","unstructured":"Attard LM, Gatt A, Bertoletti L, Delluc A, Riva N. Direct oral anticoagulants for the prevention and acute treatment of cancer-associated thrombosis. Vasc Health Risk Manag. 2022;18:793\u2013807.","journal-title":"Vasc Health Risk Manag"},{"key":"1232_CR16","first-page":"3003","volume":"109","author":"Q Wei","year":"2023","unstructured":"Wei Q, Wei ZQ, Jing CQ, Li YX, Zhou DB, Lin MB, He XL, Li F, Liu Q, Zheng JY, Wang GY, Tu SL, Wang ZJ, Li A, Xiao G, Zhuang J, Bai L, Huang H, Li Y, Song W, Liang ZL, Shen ZL, Liu FL, Dai Y, Zhou XJ, Dong M, Wang H, Qiu J, Zhou L, Li XX, Wang ZQ, Zhang H, Wang Q, Pang MH, Wei HB, Hu ZQ, Yan YD, Che Y, Gu ZC, Yao HW, Zhang ZT, for the CRCVTEi. Incidence, prevention, risk factors, and prediction of venous thromboembolism in Chinese patients after colorectal cancer surgery: a prospective, multicenter cohort study. Int J Surg. 2023;109:3003\u201312.","journal-title":"Int J Surg"},{"key":"1232_CR17","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1007\/s11605-014-2647-5","volume":"18","author":"Z Moghadamyeghaneh","year":"2014","unstructured":"Moghadamyeghaneh Z, Hanna MH, Carmichael JC, Nguyen NT, Stamos MJ. A nationwide analysis of postoperative deep vein thrombosis and pulmonary embolism in colon and rectal surgery. J Gastrointest Surg. 2014;18:2169\u201377.","journal-title":"J Gastrointest Surg"},{"key":"1232_CR18","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1007\/s11605-019-04354-2","volume":"24","author":"CJR Schlick","year":"2020","unstructured":"Schlick CJR, Liu JY, Yang AD, Bentrem DJ, Bilimoria KY, Merkow RP. Pre-operative, intra-operative, and post-operative factors associated with post-discharge venous thromboembolism following colorectal cancer resection. J Gastrointest Surg. 2020;24:144\u201354.","journal-title":"J Gastrointest Surg"},{"key":"1232_CR19","first-page":"1","volume":"30","author":"M Marshall-Webb","year":"2017","unstructured":"Marshall-Webb M, Bright T, Price T, Thompson SK, Watson DI. Venous thromboembolism in patients with esophageal or gastric cancer undergoing neoadjuvant chemotherapy. Dis Esoph Off J Int Soc Dis Esoph. 2017;30:1\u20137.","journal-title":"Dis Esoph Off J Int Soc Dis Esoph"},{"key":"1232_CR20","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.burns.2018.08.006","volume":"45","author":"Q Li","year":"2019","unstructured":"Li Q, Ba T, Wang LF, Chen Q, Li F, Xue Y. Stratification of venous thromboembolism risk in burn patients by Caprini score. Burns\u202f: J Int Soc Burn Injur. 2019;45:140\u20135.","journal-title":"Burns : J Int Soc Burn Injur"},{"key":"1232_CR21","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1093\/bjs\/znad035","volume":"110","author":"T Singh","year":"2023","unstructured":"Singh T, Lavikainen LI, Halme ALE, Aaltonen R, Agarwal A, Blanker MH, Bolsunovskyi K, Cartwright R, Garc\u00eda-Perdomo H, Gutschon R, Lee Y, Pourjamal N, Vernooij RWM, Violette PD, Haukka J, Guyatt GH, Tikkinen KAO. Timing of symptomatic venous thromboembolism after surgery: meta-analysis. Br J Surg. 2023;110:553\u201361.","journal-title":"Br J Surg"},{"key":"1232_CR22","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1097\/SLA.0000000000006376","volume":"280","author":"A Booth","year":"2024","unstructured":"Booth A, Brinton D, Donahue C, Westfal M, George V, Maxwell PJ, Simpson K, Mahvi D, Curran T. Extended pharmacologic prophylaxis for venous thromboembolism after colon cancer surgery is associated with improved long-term survival: a natural experiment in the chemotherapeutic benefit of heparin derivatives. Ann Surg. 2024;280:595\u2013603.","journal-title":"Ann Surg"},{"key":"1232_CR23","doi-asserted-by":"publisher","first-page":"2384","DOI":"10.1111\/j.1538-7836.2006.02153.x","volume":"4","author":"MS Rasmussen","year":"2006","unstructured":"Rasmussen MS, Jorgensen LN, Wille-Jorgensen P, Nielsen JD, Horn A, Mohn AC, Somod L, Olsen B, Investigators F. Prolonged prophylaxis with dalteparin to prevent late thromboembolic complications in patients undergoing major abdominal surgery: a multicenter randomized open-label study. J Thromb Haemost. 2006;4:2384\u201390.","journal-title":"J Thromb Haemost"},{"key":"1232_CR24","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1056\/NEJMoa012385","volume":"346","author":"D Bergqvist","year":"2002","unstructured":"Bergqvist D, Agnelli G, Cohen AT, Eldor A, Nilsson PE, Le Moigne-Amrani A, Dietrich-Neto F, Investigators EI. Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer. New Engl J Med. 2002;346:975\u201380.","journal-title":"New Engl J Med"},{"key":"1232_CR25","doi-asserted-by":"publisher","first-page":"e071375","DOI":"10.1136\/bmj-2022-071375","volume":"378","author":"RC Auer","year":"2022","unstructured":"Auer RC, Ott M, Karanicolas P, Brackstone MR, Ashamalla S, Weaver J, Tagalakis V, Boutros M, Stotland P, Marulanda AC, Moloo H, Jayaraman S, Patel S, Le Gal G, Spadafora S, MacLellan S, Trottier D, Jonker D, Asmis T, Mallick R, Pecarskie A, Ramsay T, Carrier M. Investigators P-. Efficacy and safety of extended duration to perioperative thromboprophylaxis with low molecular weight heparin on disease-free survival after surgical resection of colorectal cancer (PERIOP-01): multicentre, open label, randomised controlled trial. BMJ. 2022;378:e071375.","journal-title":"BMJ"},{"issue":"2","key":"1232_CR26","first-page":"57","volume":"8","author":"Chinese Society of Surgery","year":"2016","unstructured":"Chinese Society of Surgery. Chinese Medical Association. Guidelines for the prevention and management of perioperative thrombosis in general surgery. J Digest Oncol (Electronic Edition). 2016;8(2):57\u201362.","journal-title":"J Digest Oncol (Electronic Edition)"},{"key":"1232_CR27","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1097\/DCR.0000000000000982","volume":"61","author":"F Fleming","year":"2018","unstructured":"Fleming F, Gaertner W, Ternent CA, Finlayson E, Herzig D, Paquette IM, Feingold DL, Steele SR. The American Society of Colon and Rectal Surgeons clinical practice guideline for the prevention of venous thromboembolic disease in colorectal surgery. Dis Colon Rectum. 2018;61:14\u201320.","journal-title":"Dis Colon Rectum"},{"key":"1232_CR28","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1200\/JCO.19.01461","volume":"38","author":"NS Key","year":"2020","unstructured":"Key NS, Khorana AA, Kuderer NM, Bohlke K, Lee AYY, Arcelus JI, Wong SL, Balaban EP, Flowers CR, Francis CW, Gates LE, Kakkar AK, Levine MN, Liebman HA, Tempero MA, Lyman GH, Falanga A. Venous thromboembolism prophylaxis and treatment in patients with cancer: ASCO clinical practice guideline update. J Clin Oncol Off J Am Soc Clin Oncol. 2020;38:496\u2013520.","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"1232_CR29","doi-asserted-by":"crossref","unstructured":"Donahue C, Brinton D, Booth A, Westfal M, George V, Maxwell PJt, Simpson K, Curran T. Guideline concordant extended pharmacologic venous thromboembolism prophylaxis utilization after colorectal cancer resection is low regardless of patient factors or hospital characteristics. Diseases of the colon and rectum 2024.","DOI":"10.1097\/DCR.0000000000003616"},{"key":"1232_CR30","doi-asserted-by":"publisher","first-page":"e2335311","DOI":"10.1001\/jamanetworkopen.2023.35311","volume":"6","author":"CD Logan","year":"2023","unstructured":"Logan CD, Hudnall MT, Schlick CJR, French DD, Bartle B, Vitello D, Patel HD, Woldanski LM, Abbott DE, Merkow RP, Odell DD, Bentrem DJ. Venous thromboembolism chemoprophylaxis adherence rates after major cancer surgery. JAMA Netw Open. 2023;6:e2335311.","journal-title":"JAMA Netw Open"},{"key":"1232_CR31","first-page":"714","volume":"67","author":"SP Broccard","year":"2024","unstructured":"Broccard SP, Edwards MA, Brennan ER, Spaulding AC, DeLeon MF, Mishra N, Casler JD, Colibaseanu DT. Room for improvement: the impact of guideline-recommended extended thromboprophylaxis in patients undergoing abdominal surgery for colorectal and anal cancer at a tertiary referral center. Dis Colon Rectum. 2024;67:714\u201322.","journal-title":"Dis Colon Rectum"},{"key":"1232_CR32","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1007\/s11605-019-04206-z","volume":"24","author":"IL Leeds","year":"2020","unstructured":"Leeds IL, Canner JK, DiBrito SR, Safar B. Justifying total costs of extended venothromboembolism prophylaxis after colorectal cancer surgery. J Gastroint Surg Off J Soc Surg Alimen Tract. 2020;24:677\u201387.","journal-title":"J Gastroint Surg Off J Soc Surg Alimen Tract"},{"key":"1232_CR33","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1097\/DCR.0000000000001650","volume":"63","author":"A Mukkamala","year":"2020","unstructured":"Mukkamala A, Montgomery JR, De Roo AC, Ogilvie JW Jr, Regenbogen SE. Population-based analysis of adherence to postdischarge extended venous thromboembolism prophylaxis after colorectal resection. Dis Colon Rectum. 2020;63:911\u20137.","journal-title":"Dis Colon Rectum"},{"key":"1232_CR34","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1007\/s11239-022-02733-2","volume":"55","author":"TJ Aiken","year":"2023","unstructured":"Aiken TJ, King R, Russell MM, Regenbogen SE, Lawson E, Zafar SN. Venous thromboembolism prophylaxis following colorectal surgery: a survey of American Society of Colon and Rectal Surgery (ASCRS) member surgeons. J Thromb Thrombolysis. 2023;55:376\u201381.","journal-title":"J Thromb Thrombolysis"},{"issue":"5","key":"1232_CR35","first-page":"551","volume":"40","author":"HW Yao","year":"2020","unstructured":"Yao HW, Han JG, Zhang ZT. Questioniare analysis of the status of venous thromboembolism after colorectal surgery in China. Chinese J Pract Surg. 2020;40(5):551\u20136.","journal-title":"Chinese J Pract Surg"},{"key":"1232_CR36","doi-asserted-by":"publisher","first-page":"233","DOI":"10.2217\/crc.13.22","volume":"2","author":"JC Iannuzzi","year":"2013","unstructured":"Iannuzzi JC, Rickles AS, Kelly KN, Monson JRT, Fleming FJ. Prediction of venous thromboembolism after surgery for colorectal cancer: a prevention paradigm. Colorectal Cancer. 2013;2:233\u201342.","journal-title":"Colorectal Cancer"},{"key":"1232_CR37","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1182\/blood.2022016866","volume":"140","author":"GA Soff","year":"2022","unstructured":"Soff GA. Rivaroxaban after laparoscopic cancer surgery. Blood. 2022;140:804\u20135.","journal-title":"Blood"},{"key":"1232_CR38","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.jamcollsurg.2012.12.004","volume":"216","author":"MF Monn","year":"2013","unstructured":"Monn MF, Haut ER, Lau BD, Streiff M, Wick EC, Efron JE, Gearhart SL. Is venous thromboembolism in colorectal surgery patients preventable or inevitable? One institution\u2019s experience. J Am Coll Surg. 2013;216:395-401.e1.","journal-title":"J Am Coll Surg"},{"key":"1232_CR39","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.amjsurg.2015.10.019","volume":"213","author":"M Yasui","year":"2017","unstructured":"Yasui M, Ikeda M, Miyake M, Ide Y, Okuyama M, Shingai T, Kitani K, Ikenaga M, Hasegawa J, Akamatsu H, Murata K, Takemasa I, Mizushima T, Yamamoto H, Sekimoto M, Nezu R, Doki Y, Mori M. Comparison of bleeding risks related to venous thromboembolism prophylaxis in laparoscopic vs open colorectal cancer surgery: a multicenter study in Japanese patients. Am J Surg. 2017;213:43\u20139.","journal-title":"Am J Surg"},{"key":"1232_CR40","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1111\/codi.13910","volume":"19","author":"MMI Vendler","year":"2017","unstructured":"Vendler MMI, Haidari TA, Waage JE, Kleif J, Kristensen B, Gogenur I, Bertelsen CA. Copenhagen cOmplete Mesocolic Excision Study g. Incidence of venous thromboembolic events in enhanced recovery after surgery for colon cancer: a retrospective, population-based cohort study. Colorectal Dis. 2017;19:393\u2013401.","journal-title":"Colorectal Dis"},{"issue":"46","key":"1232_CR41","first-page":"51","volume":"237","author":"Baastrup NN, Buch AK, Gundestrup AK, Olsen ASF, Kleif J, Al-Najami I, Deding U, Bertelsen CA, Group CICcMESIs, Danish Colorectal Cancer G","year":"2024","unstructured":"Baastrup NN, Buch AK, Gundestrup AK, Olsen ASF, Kleif J, Al-Najami I, Deding U, Bertelsen CA, Group CICcMESIs, Danish Colorectal Cancer G. The incidence of venous thromboembolism after curative colon cancer surgery within an enhanced recovery after surgery programme. Thromb Res. 2024;237(46):51.","journal-title":"Thromb Res"},{"key":"1232_CR42","first-page":"31","volume":"116","author":"J Beyer-Westendorf","year":"2019","unstructured":"Beyer-Westendorf J, Klamroth R, Kreher S, Langer F, Matzdorff A, Riess H. Non-vitamin K antagonist oral anticoagulants (NOAC) as an alternative treatment option in tumor-related venous thromboembolism. Deutsches Arzteblatt Int. 2019;116:31\u20138.","journal-title":"Deutsches Arzteblatt Int"},{"key":"1232_CR43","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1053\/j.seminoncol.2016.11.009","volume":"43","author":"SJ Karakatsanis","year":"2016","unstructured":"Karakatsanis SJ, Roumpi A, Syrigos KN. The use of novel oral anticoagulants in cancer patients with venous thromboembolism. Semin Oncol. 2016;43:655\u201365.","journal-title":"Semin Oncol"},{"key":"1232_CR44","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1182\/bloodadvances.2020003442","volume":"5","author":"GH Lyman","year":"2021","unstructured":"Lyman GH, Carrier M, Ay C, Di Nisio M, Hicks LK, Khorana AA, Leavitt AD, Lee AYY, Macbeth F, Morgan RL, Noble S, Sexton EA, Stenehjem D, Wiercioch W, Kahale LA, Alonso-Coello P. American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer. Blood Adv. 2021;5:927\u201374.","journal-title":"Blood Adv"},{"key":"1232_CR45","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1002\/rth2.12359","volume":"4","author":"F Moik","year":"2020","unstructured":"Moik F, Posch F, Zielinski C, Pabinger I, Ay C. Direct oral anticoagulants compared to low-molecular-weight heparin for the treatment of cancer-associated thrombosis: updated systematic review and meta-analysis of randomized controlled trials. Res Pract Thromb Haemost. 2020;4:550\u201361.","journal-title":"Res Pract Thromb Haemost"},{"key":"1232_CR46","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1056\/NEJMoa1915103","volume":"382","author":"G Agnelli","year":"2020","unstructured":"Agnelli G, Becattini C, Meyer G, Mu\u00f1oz A, Huisman MV, Connors JM, Cohen A, Bauersachs R, Brenner B, Torbicki A, Sueiro MR, Lambert C, Gussoni G, Campanini M, Fontanella A, Vescovo G, Verso M. Apixaban for the treatment of venous thromboembolism associated with cancer. N Engl J Med. 2020;382:1599\u2013607.","journal-title":"N Engl J Med"},{"key":"1232_CR47","doi-asserted-by":"publisher","first-page":"e2325283","DOI":"10.1001\/jamanetworkopen.2023.25283","volume":"6","author":"IB Riaz","year":"2023","unstructured":"Riaz IB, Fuentes H, Deng Y, Naqvi SAA, Yao X, Sangaralingham LR, Houghton DE, Padrnos LJ, Shamoun FE, Wysokinski WE, McBane RD 2nd. Comparative effectiveness of anticoagulants in patients with cancer-associated thrombosis. JAMA Netw Open. 2023;6:e2325283.","journal-title":"JAMA Netw Open"},{"key":"1232_CR48","doi-asserted-by":"publisher","first-page":"1373635","DOI":"10.3389\/fphar.2024.1373635","volume":"15","author":"S Wu","year":"2024","unstructured":"Wu S, Wang H, Li C, Tao J, Zhu X, Dai H, Duan H, Hu T, Li M, Qu F, Wei Y, Wang C, Zhang J. Efficacy and safety of direct oral anticoagulants for preventing venous thromboembolism in hospitalized cancer patients: a national multicenter retrospective cohort study. Front Pharmacol. 2024;15:1373635.","journal-title":"Front Pharmacol"},{"key":"1232_CR49","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s11239-019-01844-7","volume":"47","author":"X Wang","year":"2019","unstructured":"Wang X, Wang S, Morse MA, Jiang N, Zhao Y, Song Y, Zhou L, Huang H, Zhou X, Hobeika A, Ren J, Lyerly HK. Prospective randomized comparative study on rivaroxaban and LMWH for prophylaxis of post-apheresis thrombosis in adoptive T cell immunotherapy cancer patients. J Thromb Thrombolysis. 2019;47:505\u201311.","journal-title":"J Thromb Thrombolysis"},{"key":"1232_CR50","doi-asserted-by":"publisher","first-page":"101483","DOI":"10.1016\/j.cpcardiol.2022.101483","volume":"48","author":"S Biswas","year":"2023","unstructured":"Biswas S, Bahar Y, Bahar AR, Safiriyu I, Mathai SV, Hajra A, Gupta R, Aronow WS. Present knowledge on direct oral anticoagulant and novel oral anti coagulants and their specific antidotes: a comprehensive review article. Curr Probl Cardiol. 2023;48:101483.","journal-title":"Curr Probl Cardiol"},{"key":"1232_CR51","doi-asserted-by":"publisher","first-page":"e160","DOI":"10.3346\/jkms.2019.34.e160","volume":"34","author":"JH Lee","year":"2019","unstructured":"Lee JH, Oh YM, Lee SD, Lee JS. Rivaroxaban versus low-molecular-weight heparin for venous thromboembolism in gastrointestinal and pancreatobiliary cancer. J Korean Med Sci. 2019;34:e160.","journal-title":"J Korean Med Sci"},{"key":"1232_CR52","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1056\/NEJMoa1814630","volume":"380","author":"AA Khorana","year":"2019","unstructured":"Khorana AA, Soff GA, Kakkar AK, Vadhan-Raj S, Riess H, Wun T, Streiff MB, Garcia DA, Liebman HA, Belani CP, O\u2019Reilly EM, Patel JN, Yimer HA, Wildgoose P, Burton P, Vijapurkar U, Kaul S, Eikelboom J, McBane R, Bauer KA, Kuderer NM, Lyman GH, Investigators C. Rivaroxaban for thromboprophylaxis in high-risk ambulatory patients with cancer. New Engl J Med. 2019;380:720\u20138.","journal-title":"New Engl J Med"},{"key":"1232_CR53","doi-asserted-by":"publisher","first-page":"634","DOI":"10.20996\/1819-6446-2014-10-6-634-639","volume":"10","author":"AA Rumyantsev","year":"2014","unstructured":"Rumyantsev AA, Pokataev AA, Kozlov AVJRNFVK. The problem of the use of new oral anticoagulants in cancer patients receiving chemotherapy. Rational Pharmacotherap Cardiol. 2014;10:634\u20139.","journal-title":"Rational Pharmacotherap Cardiol"},{"key":"1232_CR54","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/ajo.13737","volume":"64","author":"M Boo","year":"2024","unstructured":"Boo M, Simcock B, Sykes P, Brand A. Direct oral anticoagulants (DOACs) use for prolonged venous thromboembolism prophylaxis following surgery for gynaecological malignancies in Australia and New Zealand - a clinician survey. Aust N Z J Obstet Gynaecol. 2024;64:36\u201341.","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"1232_CR55","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.15420\/ecr.2021.55","volume":"17","author":"HN Tun","year":"2022","unstructured":"Tun HN, Kyaw MT, Rafflenbeul E, Suastegui XL. Role of direct oral anticoagulants for post-operative venous thromboembolism prophylaxis. Eur Cardiol. 2022;17:e11.","journal-title":"Eur Cardiol"},{"key":"1232_CR56","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1002\/ajh.26945","volume":"98","author":"M Zhao","year":"2023","unstructured":"Zhao M, Bao Y, Jiang C, Chen L, Xu L, Liu X, Li J, Yang Y, Jiang G, Li J, She Y, Chen Q, Shen L, Chen C. Rivaroxaban versus nadroparin for thromboprophylaxis following thoracic surgery for lung cancer: a randomized, noninferiority trial. Am J Hematol. 2023;98:1185\u201395.","journal-title":"Am J Hematol"},{"key":"1232_CR57","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s12957-024-03341-5","volume":"22","author":"H Zhou","year":"2024","unstructured":"Zhou H, Chen TT, Ye LL, Ma JJ, Zhang JH. Efficacy and safety of direct oral anticoagulants versus low-molecular-weight heparin for thromboprophylaxis after cancer surgery: a systematic review and meta-analysis. World J Surg Oncol. 2024;22:69.","journal-title":"World J Surg Oncol"},{"key":"1232_CR58","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1182\/blood.2022015796","volume":"140","author":"C Becattini","year":"2022","unstructured":"Becattini C, Pace U, Pirozzi F, Donini A, Avruscio G, Rondelli F, Boncompagni M, Chiari D, De Prizio M, Visona A, De Luca R, Guerra F, Muratore A, Portale G, Milone M, Castagnoli G, Righini M, Martellucci J, Persiani R, Frasson S, Dentali F, Delrio P, Campanini M, Gussoni G, Vedovati MC, Agnelli G. Rivaroxaban vs placebo for extended antithrombotic prophylaxis after laparoscopic surgery for colorectal cancer. Blood. 2022;140:900\u20138.","journal-title":"Blood"}],"container-title":["Journal of Gastrointestinal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-025-01232-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12029-025-01232-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-025-01232-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T13:03:18Z","timestamp":1745326998000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12029-025-01232-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,22]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1232"],"URL":"https:\/\/doi.org\/10.1007\/s12029-025-01232-w","relation":{},"ISSN":["1941-6628","1941-6636"],"issn-type":[{"value":"1941-6628","type":"print"},{"value":"1941-6636","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,22]]},"assertion":[{"value":"12 April 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest Statement"}}],"article-number":"104"}}